greeksoup/ stock research

UnitedHealth Group (UNH) FY2021 results: revenue $287.6 billion, up 11.8% on the year

UnitedHealth Group Inc. (UNH) reported revenue of $287.6 billion for fiscal 2021, the year ended 31 December 2021, up 11.8% on the year before. Net income was $17.3 billion, up 12.2%, and diluted earnings per share $18.08. The figures are the company's own, from the 10-K it filed with the SEC on 15 February 2022.

Revenue
$287.6 billion
+11.8% on the year
FY2014FY2021
Operating margin
8.3%
8.7% a year earlier
FY2014FY2021
Net income
$17.3 billion
+12.2% on the year
FY2014FY2021
Diluted EPS
$18.08
+12.8% on the year
FY2014FY2021

this yearthe year beforeHover a bar for its figure.

The year in brief

The quarters: Q4 FY2021

Income statement (profit and loss)

$ millionFY2021FY2020FY2019On the yearLast 8 years
Revenue287,597257,141242,155+11.8%
Cost of revenue31,03430,74528,117+0.9%
Gross profit256,563226,396214,038+13.3%
Gross margin89.2%88.0%88.4%
Selling, general and administrative42,57941,70435,193+2.1%
Operating income23,97022,40519,685+7.0%
Operating margin8.3%8.7%8.1%
Interest expense1,6601,6631,704-0.2%
Pre-tax income22,31020,74217,981+7.6%
Income tax4,5784,9733,742-7.9%
Effective tax rate20.5%24.0%20.8%
Net income17,28515,40313,839+12.2%
Net margin6.0%6.0%5.7%
Diluted EPS$18.08$16.03$14.33+12.8%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2021FY2020FY2019On the yearLast 8 years
Operating cash flow22,34322,17418,463+0.8%
Capital expenditure2,4542,0512,071+19.6%
Free cash flow19,88920,12316,392-1.2%
Free cash flow margin6.9%7.8%6.8%
Cash from investing-10,372-12,532-12,699
Cash from financing-7,455-3,590-5,625
Depreciation and amortisation3,1032,8912,720+7.3%
Share-based compensation800679697+17.8%
Buybacks5,0004,2505,500+17.6%
Dividends paid5,2804,5843,932+15.2%
Dividend per share$5.60$4.83$4.14+15.9%
Diluted shares, weighted956m961m966m-0.5%
Shares outstanding at period end941m946m948m-0.5%

Balance sheet

$ millionFY2021FY2020FY2019On the yearLast 8 years
Shareholders' equity75,04568,32860,436+9.8%
Redeemable equity1,4342,2111,726-35.1%
Debt46,00343,46740,678+5.8%
Other liabilities89,72483,28371,049+7.7%
Total liabilities and equity212,206197,289173,889+7.6%
Fixed assets8,9698,6268,704+4.0%
Goodwill75,79571,33765,659+6.2%
Intangible assets10,04410,85610,349-7.5%
Investments45,64644,10240,469+3.5%
Cash and equivalents21,37516,92110,985+26.3%
Receivables14,21612,87011,822+10.5%
Inventory2,900n/an/a
Other assets33,26132,57725,901+2.1%
Total assets212,206197,289173,889+7.6%

10-K for the year ended 31 December 2021, filed 15 February 2022: the filing.